Opportunity overview
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 Offer reference number: CM/PHS/25/5728 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments: 7NAT (National) 01/12/2025 to 31/05/2027 (18 months) CM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments aflibercept 2mg: NOFE: (North of England) 01/12/2025 to 31/05/2027 (18 months) SOFE: (South of England) 01/12/2025 to 31/05/2027 (18 months) MAE: (Midlands and East) 01/12/2025 to 31/05/2027 (18 months) LNW: (London) 01/12/2025 to 31/05/2027 (18 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Provision of Licensed Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabetic retinopathy (PDR) • visual impairment due to diabetic macular oedema (DME) • visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy • vision impairment associated with chronic diabetic macular oedema, (DME) • visual impairment due to myopic choroidal neovascularisation (myopic CNV) • retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease • inflammation of the posterior segment of the eye presenting as non-infectious uveitis • prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
ABBVIE LTD
- Shared published award value
- £688.8m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 10 awarded suppliers
- Award ID
- 1
- Status
- pending
- Identifier
- GB-COH 08004972
- Location
- Maidenhead, UKJ11, SL6 4UB, United Kingdom
ALIMERA SCIENCES LIMITED
- Shared published award value
- £688.8m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 10 awarded suppliers
- Award ID
- 1
- Status
- pending
- Identifier
- GB-COH 08018355
- Location
- Hook, UKJ37, RG27 9XA, United Kingdom
BAYER PUBLIC LIMITED COMPANY
- Shared published award value
- £688.8m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 10 awarded suppliers
- Award ID
- 1
- Status
- pending
- Identifier
- GB-COH 00935048
- Location
- Reading, UKJ11, RG26AD, United Kingdom
BIOGEN IDEC LIMITED
- Shared published award value
- £688.8m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 10 awarded suppliers
- Award ID
- 1
- Status
- pending
- Identifier
- GB-COH 01497267
- Location
- Maidenhead, UKJ11, SL6 3UD, United Kingdom
NOVARTIS PHARMACEUTICALS UK LIMITED
- Shared published award value
- £688.8m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 10 awarded suppliers
- Award ID
- 1
- Status
- pending
- Identifier
- GB-COH 00119006
- Location
- London, UKI33, W12 7FQ, United Kingdom
ORION PHARMA (UK) LIMITED
- Shared published award value
- £688.8m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 10 awarded suppliers
- Award ID
- 1
- Status
- pending
- Identifier
- GB-COH 02281057
- Location
- London, UKI31, EC3M 7AF, United Kingdom
Outlook Therapeutics, Inc.
- Shared published award value
- £688.8m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 10 awarded suppliers
- Award ID
- 1
- Status
- pending
- Identifier
- GB-COH 08179857
- Location
- #100 Iselin, US, NJ 08830, United States
ROCHE PRODUCTS LIMITED
- Shared published award value
- £688.8m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 10 awarded suppliers
- Award ID
- 1
- Status
- pending
- Identifier
- GB-COH 00100674
- Location
- Welwyn Garden City, UKH23, AL7 1TW, United Kingdom
TEVA UK LIMITED
- Shared published award value
- £688.8m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 10 awarded suppliers
- Award ID
- 1
- Status
- pending
- Identifier
- GB-COH 00302461
- Location
- Castleford, UKE45, WF10 5HX, United Kingdom
THORNTON & ROSS LIMITED
- Shared published award value
- £688.8m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 10 awarded suppliers
- Award ID
- 1
- Status
- pending
- Identifier
- GB-COH 00185947
- Location
- Huddersfield, UKE44, HD7 5QH, United Kingdom
Abbvie Ltd
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-PPON PHRQ-1133-WGCH
- Location
- Maidenhead, UKJ11, SL6 4UB, United Kingdom
Alimera Sciences
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-PPON PYCZ-7339-TCCT
- Location
- Hook, UKJ37, RG27 9XA, United Kingdom
Bayer Plc
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-COH 00935048
- Location
- Reading, UKJ11, RG26AD, United Kingdom
Biogen
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-PPON PTGT-3385-PBMQ
- Location
- Maidenhead, UKJ11, SL63UD, United Kingdom
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-PPON PQQC-5869-LMVX
- Location
- London, UKI31, WC2B 5AH, United Kingdom
CELLTRION HEALTHCARE UNITED KINGDOM LIMITED
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-COH 11685363
- Location
- Uxbridge, UKI74, UB8 1JG, United Kingdom
MDBIOLOGICS LTD
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-COH 15579040
- Location
- London, UKI31, WC2H 9JQ, United Kingdom
Novartis Pharmaceuticals UK Ltd
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-PPON PJTX-5182-QVLR
- Location
- London, UKI33, W12 7FQ, United Kingdom
Orion Pharma (UK) Ltd
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-PPON PJZQ-1429-ZBVY
- Location
- London, UKI31, EC3M 7AF, United Kingdom
Outlook Therapeutics, Inc.
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-PPON PGZH-1763-NPGX
- Location
- Surrey, UKJ25, GU1 1UN, United Kingdom
Roche Products Ltd
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-PPON PXCG-4172-CHYM
- Location
- Welwyn Garden City, UKH23, AL7 1TW, United Kingdom
SANDOZ LIMITED
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-COH 01547204
- Location
- Bracknell, UKJ11, RG12 1RF, United Kingdom
Teva UK Limited
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-PPON PWDD-6894-DXRM
- Location
- Castleford, UKE45, WF10 5HX, United Kingdom
Thornton and Ross Ltd
- Shared published award value
- £782.9m
- Awarded
- 30 Jul 2025
- Suppliers
- One of 14 awarded suppliers
- Award ID
- 2
- Status
- active
- Identifier
- GB-PPON PWYH-6892-QYNN
- Location
- Huddersfield, UKE44, HD7 5QH, United Kingdom
- Shared contract value
- £782.9m
- Awarded
- Not supplied
- Contract signed
- 21 Sept 2025
- Including VAT
- £939.5m
- Suppliers
- One of 5 awarded suppliers
- Award ID
- 3
- Status
- active
- Identifier
- GB-PPON PQQC-5869-LMVX
- Location
- London, UKI31, WC2B 5AH, United Kingdom
Bayer Plc
- Shared contract value
- £782.9m
- Awarded
- Not supplied
- Contract signed
- 21 Sept 2025
- Including VAT
- £939.5m
- Suppliers
- One of 5 awarded suppliers
- Award ID
- 3
- Status
- active
- Identifier
- GB-PPON PWRY-2527-LDRY
- Location
- Reading, UKJ11, RG2 6AD, United Kingdom
Celltrion Healthcare United Kingdom Limited
- Shared contract value
- £782.9m
- Awarded
- Not supplied
- Contract signed
- 21 Sept 2025
- Including VAT
- £939.5m
- Suppliers
- One of 5 awarded suppliers
- Award ID
- 3
- Status
- active
- Identifier
- GB-PPON PYQL-4248-PXXY
- Location
- Uxbridge, UKI74, UB8 1JG, United Kingdom
MDBIOLOGICS LTD
- Shared contract value
- £782.9m
- Awarded
- Not supplied
- Contract signed
- 21 Sept 2025
- Including VAT
- £939.5m
- Suppliers
- One of 5 awarded suppliers
- Award ID
- 3
- Status
- active
- Identifier
- GB-PPON PMHC-1596-RTNX
- Location
- London, UKI31, WC2H 9JQ, United Kingdom
SANDOZ LIMITED
- Shared contract value
- £782.9m
- Awarded
- Not supplied
- Contract signed
- 21 Sept 2025
- Including VAT
- £939.5m
- Suppliers
- One of 5 awarded suppliers
- Award ID
- 3
- Status
- active
- Identifier
- GB-PPON PNQL-1548-CYBZ
- Location
- Bracknell, UKJ11, RG12 1RF, United Kingdom
Classification
- CPV33600000 — Pharmaceutical products
- CPV33690000 — Various medicinal products
Lots
- CM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments:£709.5m
- CM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments a£810.9m
Documents and notices
- Contract details notice on Find a TenderOpen source ↗
- Contract award notice on Find a TenderOpen source ↗
- Tender notice on Find a TenderOpen source ↗
- Tender notice on Find a TenderOpen source ↗
- ITO DocumentsOpen source ↗
- Framework Agreement and Terms and Conditions - Lot 1Open source ↗
- Framework Agreement and Terms and Conditions - Lot 2Open source ↗